Milica Radisic – Center Director
- Canada Research Chair in Functional Cardiovascular Tissue Engineering
- Senior Scientist, Toronto General Research Institute
- Associate Chair–Research, Department of Chemical Engineering and Applied Chemistry
- Director, NSERC CREATE Training Program in Organ-on-a-Chip Engineering & Entrepreneurship
- Professor, Department of Department of Chemical Engineering and Applied Chemistry
Dr. Radisic obtained a B.Eng. from McMaster University, and a Ph.D. form the Massachusetts Institute of Technology. She is a Fellow of the Royal Society of Canada–Academy of Science, Canadian Academy of Engineering, the American Institute for Medical & Biological Engineering and Tissue Engineering & Regenerative Medicine Society. She received numerous awards and fellowships, including MIT Technology Review Top 35 Innovators under 35. She was a recipient of the Professional Engineers Ontario–Young Engineer Medal in 2011, Engineers Canada Young Engineer Achievement Award in 2012, Queen Elizabeth II Diamond Jubilee Medal in 2013, NSERC E.W.R Steacie Fellowship in 2014, YWC Toronto Woman of Distinction Award in 2018, and OPEA Research & Development Medal in 2019 to name a few. Her research focuses on organ-on-a-chip engineering and development of new biomaterials that promote healing and attenuate scarring. She developed new methods to mature iPSC derived cardiac tissues using electrical stimulation. Currently, she holds research funding from CIHR, NSERC, CFI, ORF, NIH, and the Heart and Stroke Foundation. She is an Associate Editor for ACS Biomaterials Science & Engineering, a member of the Editorial Board of Tissue Engineering, Advanced Drug Delivery Reviews, Regenerative Biomaterials, Advanced Biosystems, Journal of Molecular and Cellular Cardiology and eLife. She serves on review panels for Canadian Institutes of Health Research and the National Institutes of Health. She is actively involved with BMES (Cardiovascular Track Chair in 2013 and 2104) and TERMIS-AM (Council member, Chair of the Membership Committee). She was a co-organizer of a 2017 Keystone Symposium, “Engineered Cells and Tissues as Platforms for Discovery and Therapy”. She served on the Board of Directors for Ontario Society of Professional Engineers and currently serves on the Board of Directors of Canadian Biomaterials Society. Her research findings were presented in over 200 research papers, reviews and book chapters with h-index of 61 and over 13,000 citations. Her publications appear in prestigious journals such as: Cell, Nature Materials, Nature Methods, Nature Protocols, Nature Communications, PNAS etc. In 2014, she co-founded an award-winning company TARA Biosystems that uses matured human engineered heart tissues in drug development. TARA currently tests drugs for major pharmaceutical companies. In 2017, she founded Quthero Inc, a company focused on disrupting the skin regeneration and wound healing market through the use of proprietary Q-gel to promote scar-free wound healing.